Physician Practices & Urgent Care

It’s reported that 85% of patient visits happen outside of a hospital, increasing the need for testing in the ambulatory care setting.  But the diagnosis of infection within the physician practice has always been a challenge.  For years, providers have relied on culture as the “gold standard” to identify an infection.

Not only is culture losing effectiveness, but it’s becoming more difficult for today’s pathogens to grow in culture mediums. Further, the time and difficulty associated with receiving accurate culture results has led to reliance on empirical treatment, which has become increasingly more ineffective as a provider is more likely to “guess” the wrong treatment due to prevalence of resistant infections.  Treating empirically is putting patients at increased risk of subsequent infections with antibiotic-resistant pathogens including MRSA, VRE, multi-drug resistant gram-negative bacilli and C. Difficile colitis.

Physician practices need the ability to quickly and accurately detect whether an infection is viral or bacterial and identify the strain of the causative pathogen(s).

By implementing comprehensive rapid diagnostics, providers receive results that enable them to better meet their patients’ needs, start the correct pathway to treatment within hours and help save costs, conserve antibiotics and slow antimicrobial resistance at a system-wide level.   And while employing these leading-edge diagnostics can translate into a competitive edge and more patient referrals, practices can also realize the benefit of a new revenue stream by capturing higher value-based reimbursements associated with an improved standard of care.

Attis Healthcare’s Onsite PCR Syndromic Testing solution provides physician practices and urgent care centers with the diagnostic tool they need to increase profitability while improving patient outcomes and promoting antibiotic stewardship.

Onsite PCR Syndromic Testing

Advanced Real Time-PCR technology allows for the most rapid pathogen identification, quantification and detection of antibiotic resistance. Collected via non-invasive swab, PCR detects multiple pathogens at once, results in hours and is 3-5x more sensitive than standard culture.  In addition, PCR testing identifies the pathogen load and genetic variations that allow pathogens to become resistant to antibiotics. This is instrumental when selecting an effective antibiotic regimen for the patient and reducing unnecessary antibiotic use.

Our proprietary, turnkey tabletop solution runs 2-4 tests per hour and enables a provider to offer comprehensive, highly sensitive and accurate PCR diagnostic testing onsite.  The practice can bill and collect for the test, increasing revenue for the practice while improving patient care and outcomes.

PCR Molecular Pathogen identification is available for the detection of respiratory, urinary tract, wound, vaginitis/STI and ear infections, with antibiotic resistance detection for UTI and wound panels.

Up to 50% of all antibiotics prescribed for people are not needed or are not optimally effective as prescribed.
Our Markets
Physician Practices & Urgent Care
community hospitals
long term care
community pharmacy
workplace wellness